title: Why not performing susceptibility test for trimethoprim-sulphamethoxazole?
authors.forename: Hideharu
authors.initials: H
authors.lastname: Hagiya
mesh_terms: D000046:Academic Medical Centers; D000284:Administration, Oral; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000066491:Clinical Decision-Making; D024881:Drug Resistance, Bacterial; D024901:Drug Resistance, Multiple, Bacterial; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology / Q000652:urine; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000382:microbiology / Q000652:urine; D006801:Humans; D007564:Japan; D008826:Microbial Sensitivity Tests; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology / Q000652:urine
chemical_list: D000892:Anti-Infective Agents, Urinary; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
keywords: Antimicrobial susceptibility test (AST),; Breakpoint,; Trimethoprim-sulphamethoxazole (TMP-SMZ); minimum inhibitory concentration (MIC),